Subject: Intra-vitreal injections/implants
Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between May and August 2017?
If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].
|Lucentis (ranibizumab) Injections||Avastin (bevacizumab) Injections||Eylea (aflibercept) Injections||Illuvien (Fluocinolone) Impants||Ozudex (Dexamethasone) Implants|
|Wet Age Related Macular Degeneration (wAMD)|
|Diabetic Macular Oedema (DMO)|
|Retinal Vein Occlusion – Central or Branch (CRVO or BRVO)|
|Other eg mCNV|
|Please find information attached.
2017-513 FOI Request intra-vitreal injections implants [13 kb] Ms Excel